Skip to main content
Log in

Epidemiology and Prevalence of Gout in Mainland China: an Updated Systematic Review and Meta-Analysis

  • Medicine
  • Published:
SN Comprehensive Clinical Medicine Aims and scope Submit manuscript

Abstract

Gout is a common inflammatory joint disease. Although China is a developing country, it is an ethnically diverse country with regional economic disparities. To date, there are limited studies that investigated the gout prevalence from representative populations in mainland China. Therefore, we performed an updated systematic review and meta-analysis in order to comprehensively review all the relevant published data that reported the prevalence of gout in mainland China from 1998 to 2019. The electronic databases including PubMed and Medline were searched for peer-reviewed articles published in the selected period. Meta-analyses were conducted by using the Comprehensive Meta-Analysis software. After screening and checking for eligibility, we included 67 articles with a total of > 394,768 participants. The pooled estimate of prevalence in the general population was 1.6% (95% CI, 1.2–2.2%). Gout prevalence rates varied from 0.8 to 5% by regions. The lowest and highest prevalence of gout was found in the Northwest (0.8%) and Southwest (5.0%), respectively. The prevalence rate was higher in males than in females (1.9% (95% CI, 1.5–2.4%) vs. 0.5% (95% CI, 0.3–0.8%) (P < 0.001). All funnel plots were symmetrical and no indication of publication bias was observed for all analyses. In conclusion, the prevalence of gout was reported to be on the rise. In addition, the burden of gout is also increasing in China. With the increasing aging populations and obesity rate in mainland China, the evidence from this updated systematic review and meta-analysis will be significant to prompt for optimizing management and treatment of gout at individual and population levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Martillo MA, Nazzal L, Crittenden DB. The crystallization of monosodium urate. Curr Rheumatol Rep. 2014;16(2):400.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Kuo C-F, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11:649–62.

    Article  PubMed  Google Scholar 

  3. Multidisciplinary Expert Task Force on Hyperuricemia Related Diseases. Chinese multidisciplinary expert consensus on the diagnosis and treatment of hyperuricemia and related diseases. Chin Med J. 2017;130(20):2473–88.

    Article  CAS  Google Scholar 

  4. Kim Y, Oh H-C, Park JW, Kim I-S, Kim J-Y, Kim K-C, et al. Diagnosis and treatment of inflammatory joint disease. Hip Pelvis. 2017;29(4):211–22.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Singh JA. Racial and gender disparities among patients with gout. Curr Rheumatol Rep. 2013;15(2):307.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Roddy E. Revisiting the pathogenesis of podagra: why does gout target the foot? J Foot Ankle Res. 2011;4(1):13.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Perreault S, Nuevo J, Baumgartner S, Morlock R. Any link of gout disease control among hypertensive patients and onset of end-stage renal disease? Results from a population-based study. World J Nephrol. 2017;6(3):132–42.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Zhou H, Ma ZF, Lu Y, Du Y, Shao J, Wang L, et al. Elevated serum uric acid, hyperuricaemia and dietary patterns among adolescents in mainland China. J Pediatr Endocrinol Metab. 2020;33(4):487–93.

    Article  CAS  PubMed  Google Scholar 

  9. Chen Y, Tang Z, Huang Z, Zhou W, Li Z, Li X, et al. The prevalence of gout in mainland China from 2000 to 2016: a systematic review and meta-analysis. J Public Health. 2017;25(5):521–9.

    Article  Google Scholar 

  10. Yan S, Zhao S, Li C, Wang Y, Wang P, Wang Z, et al. A five years follow up study on patients with gout and hyperuricemia. Chin J Endocrinol Metab. 2011;27(7):548–52.

    CAS  Google Scholar 

  11. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Du H, Chen S, Wang Y, Xu L. An epidemiological investigation on community hyperuricemia and gout in Huangpu district, Shanghai. Chin J Rheumatol. 1998;2(2):1.

    Google Scholar 

  13. Jiang B, Zhang Y, Xu X, Mei H, Ding F, Wang G, et al. The prevalence of gout and hyperuricemia in Shandong province. China Public Health. 1999:27–8.

  14. Wang Q, Chen R, Du L, Zeng Q. An epidemiological and clinical study of primary gout. Chin J Intern Med. 2001;40(5):313–5.

    CAS  Google Scholar 

  15. Shao J, Mo B, Yu R, Li Z, Liu H, Xu Y. Epidemiological study on hyperuricemia and gout in community of Nanjing. Chin J Dis Control Prev. 2003;7(4):305–8.

    Google Scholar 

  16. Shi F, Gu K, Lu W, Weng W, Zhu M, Peng Y, et al. Study on the prevalence of arthritis and relevant factors in Shanghai. Chin J Epidemiol. 2003;24(12):1136–40.

    Google Scholar 

  17. Zhang X, Yu W, Sun Z, Liu D, Zhang C, Zhang L. Investigation of hyperuricemia in Haiyang city, Shandong province. Chinese J Naut Med Hyperbaric Med. 2004;11(2):112–3.

    Google Scholar 

  18. Zeng X. Epidemiological investigation on hyperuricemia and gout among railway workers in Nanning. Hei Long Jiang Med J. 2005;29(11):876–7.

    Google Scholar 

  19. Chou Y, Yan F. Survey and analysis on the health status of 546 retired cadres in Yancheng. J Baotou Med Coll. 2006;22(3):262–4.

    Google Scholar 

  20. Fang W, Huang X, Wang Y, Chen W, Zhu W, Chen J, et al. An epidemiological study of gout in population in Beijing. Basic Clin Med. 2006;26(7):781–5.

    Google Scholar 

  21. Mao Y, Zhou L, Ye H, Huang T, Chen C, Du J, et al. Epidemiological survey on prevalences of hyperuricemia and gout in staff of a petrochemical corporation in Ningbo. Chin J Endocrinol Metab. 2006;22(4):338–41.

    Google Scholar 

  22. Miao Z, Zhao S, Wang Y, Li C, Wang Z, Chen Y, et al. Epidemic characteristics of gout and primary hyperuricemia in Shandong coastal area: a randomized stratified cluster sampling survey. J Clin Rehab Tissue Eng Res. 2007;11(30):6087–91.

    CAS  Google Scholar 

  23. Miao Z, Zhao S, Wang Y, Li C, Wang Z, Chen Y, et al. Epidemiological survey of hyperuricemia and gout in coastal areas of Shandong Province. Chin J Endocrinol Metab. 2006;22(5):421–5.

    CAS  Google Scholar 

  24. Zhang X, Yu W, Yu L, Zhang L, Yu Y. An epidemiologic study on hyperuricaemia and gout in residents of coastal areas of Haiyang City in Shandong. Chin J Gen Pract. 2006;5(4):216–9.

    Google Scholar 

  25. Han L, Zhang W, He W. Epidemiological survey on gout prevalence among young and middle-aged people in Qingdao area. Chin J Misdiagn. 2007;7(13):3176–7.

    Google Scholar 

  26. Wu W, Guo J, Yang W, Luo H. The prevalence of hyperuricemia and gout among 1482 subjects for health check in Guangzhou. Hainan Med J. 2007a;18(9):110.

    Google Scholar 

  27. Wu W, Liu Y, Luo H, Guo J. The epidemiology of hyperuricemia and gout in youth and middle-aged residents in a community of Guangzhou City. Clin Med China. 2007b;23(z1):31–3.

    Google Scholar 

  28. Yao Z, Jiang S, Liu H, Wan X, Ding Z. Epidemiological study on hyperuricemia and gout in the coastal area of Qingdao city. Chin J Rheumatol. 2007;11(11):672–5.

    Google Scholar 

  29. Pan P. Epidemiological investigation of gout in Shenzhen area. Chin J Misdiagn. 2008;8(31):7807–8.

    Google Scholar 

  30. Wu W, Guo J, Yang W, Zhong Z, Liu Y, Luo H. Epidemliology of hyperuricemia and gout in a community in Gilangzhon. Chinese J Gen Pract. 2008;6(7):728–9.

    Google Scholar 

  31. Ye Z, Gao L, Yang C, Xu J. Analysis on current situation of chronic disease and its influencing factors in insular residents. ChinJ Public Health Mgmt. 2008;24(5):520–1.

    Google Scholar 

  32. Zeng X, Chen B, Zeng F, Hou C, He Q, Huang L, et al. Epidemiological survey of common rheumatic in Guangxi Nanning Zhuang population. J Pract Med. 2008;24(8):1432–4.

    Google Scholar 

  33. Chen X, Yang H, Yang J. Investigation on the prevalence of hyperuricemia and gout in urban residents in Dali, Yunnan province. China Pract Med. 2009;4(10):257–9.

    Google Scholar 

  34. Jia Y, Cui L, Yang W, Shu R, Song H, Han Y, et al. Epidemiological survey on morbidity of hyperuricemia and gout in Tangshan Mining District. Chin J Coal Industry Med. 2009;12(12):1933–5.

    Google Scholar 

  35. Li M, Yu C, Chen Z, Liu Y, Xu J, Li F. Investigation on health status and health service demand of urban and rural residents in Huicheng district, Huizhou city. Contemp Med. 2010;16(31):1–3.

    Google Scholar 

  36. Wang K, Fu Z, Li C, Liu S, Miao Z, Yan S, et al. Survey of hyperuricemia and gout in two villages of Fushan township of Zhaoyuan in Shandong province. Acta Academiae Med Qingdao Universitatis. 2010;46(5):380–3.

    Google Scholar 

  37. Yu J, Yang T, Diao W, Cai X, Li T, Zhong H, et al. Epidemiological study on hyperuricemia and gout in Foshan areas, Guangdong province. Chin J Epidemiol. 2010;31(8):860–2.

    CAS  Google Scholar 

  38. Zhu Y, Nie S. Analysis of physical examination results of elderly people in Pingjiang district, Suzhou and thoughts on follow-up management. J Commun Med. 2010;8(1):3–5.

    Google Scholar 

  39. Zou J, Yang J, Zhang Y, Tian L, Dong J. Spectrum of rheumatoid diseases of Qiang in Mianyang before and after Wenchuan earthquake. Med J West China. 2010;22(8):1558–60.

    Google Scholar 

  40. Guli A, Zhang C, Chen H. Correlation between hyperuricemia and risk factors among senior intellectuals in colleges and universities in Lanzhou. Chinese J Gerontol. 2011;31(9):1508–9.

    Google Scholar 

  41. Hu Y, Maimaiti Y, Aisha A. Epidemiological survey of hyperuricemia and gout in Uygur population of Xinjiang. J Chin Pract Diagn Ther. 2011;25(9):876–7,81.

    Google Scholar 

  42. Yuan S, Li X, Ma Y, Yang Y, Ma X, Huang Y, et al. Epidemiological survey of hyperuricemia and gout in Xinjiang adult population. Chin J Endocrinol Metab. 2011;27(7).

  43. Zhang J, Xu Q, Ying X, Xu Y, Lan X, He X, et al. Investigation and analysis of unhealthy behaviors of senior managers in private enterprises in western Zhejiang province. Chin Rural Health Serv Admin. 2011;31(9):959–60.

    Google Scholar 

  44. Zou J, Yang J, Dong J, Zhang Y, Tian L, Gu Y. Epidemiological investigation of hyperuricemia and gout in Beichuan Qiang people. Contemp Med. 2011;17(31):12–4.

    Google Scholar 

  45. Cheng L, Jiang J. Analysis of factors affecting elderly men with gout in community. China Modern Doctor. 2012;50(2):9–10.

    Google Scholar 

  46. Gu Y, Zhong X, Wang F. An epidemiological study on rheumatic immunity diseases of Qiang ethnic group in Beichuan after Wenchuan earthquake. Chin J Ethnomed Ethnopharm. 2012;21(8):28,30.

    Google Scholar 

  47. Jiang X. Epidemiological investigation and analysis of chronic diseases in Hengxi town, Ningbo city in 2011. Modern Pract Med. 2012;24(10):1153–5.

    Google Scholar 

  48. Li X, Lin C, Liu Y, Wang L, Yu W. Investigation of hyperuricemia in 1573 army cadres. ChinJ Health Care Med. 2012;14(6):445–8.

    CAS  Google Scholar 

  49. Song Y, Zhu K, Yu H, Zhuang X. Significance of establishing chronic disease spectrum of residents in Haizhu District, Guangzhou. J Public Health Prev Med. 2012;23(4):39–41.

    Google Scholar 

  50. Wu L, Song X, Ku B, Shi Y, Huang C, Huang J, et al. Epidemiological study on hyperuricemia and gout in Uygur population in Turpan area of Xinjiang. J Peking Univ (Health Sci). 2012;44(2):250–3.

    CAS  Google Scholar 

  51. Huang J, Zhou B, Chen S, Dong J. A cross-sectional study on gout and hyperuricemia in community population. Zhejiang J Prev Med. 2013;25(7):8–10.

    Google Scholar 

  52. Chen R, Bai Y, Su H, Cheng N, Li H, Ding J, et al. Analysis of influencing factors of gout in occupational crowd of Jinchang city. Chin J Prev Control Chronic Dis. 2014;22(6):659–62.

    CAS  Google Scholar 

  53. Cui S, Wang X, Tian Z, Wei H, Tian X, Yi Y. Epidemiological study on hyperuricemia and gout in community of Yu County in Hebei province. Chin J Hemorheol. 2014a;4:501–3,15.

    Google Scholar 

  54. Cui S, Wei H, Tian Z, Wang X, Zhao Y, Yi Y. Investigation on the prevalence of hyperuricemia and gout in Yuxian workers in Zhangjiakou area. Clin Focus. 2014b;9.

  55. Song W, Liu J, Chen Z, Huo Y, Lin H, Zhang Y. Hyperuricemia and gout: a prevalence survey among over-40-year-old community residents in Nanchang district. Chin General Pract. 2014;17(2):181–4.

    Google Scholar 

  56. Yang F, La Z, Liu L, Lin B, Yu L, Qu N. Discussion on gout prevalence rate and its influencing factors in Lhasa residents in 2012. Yiayao Qianyan [J]. 2014;(10):26–7.

  57. Zhang P, Zhang L, Wang C, Wei S, Qiao X. A survey of hyperuricemia and gout in people over 30 years old in Xingtai mountains. Pract Prev Med. 2014;21(8):1010–2.

    CAS  Google Scholar 

  58. Zhou H, Wang S, Yi X, Yin H, Yang Y, Ji Y, et al. Investigation on nutrition and health status of elderly population in Lishui district, Nanjing city. Chongqing Med [J]. 2014;43(25):3333–5.

    Google Scholar 

  59. Bate B, Da J, Xia B, Chen P, Ou Y, Luo F, et al. Epidemiological investigation of hyperuricemia and gout in Bozhou, Xinjiang. World Latest Med Information. 2015;15(41):99–100.

    Google Scholar 

  60. Gong X, Wang Z, Chen M, Liu Y, Tong Y, Zhou P, et al. Investigation on the health status and demand of the empty nester in Hubei province. Med Soc. 2015;9:10–2.

    Google Scholar 

  61. Hong X, He N, Li H, Zeng Q. Research on prevalence of dyslipidemia and risk factors among 3 911 physical examination cases. Food Nutr China [J]. 2015;21(11):78–81.

    Google Scholar 

  62. Yang L, Song J, Lv L, Lv X, Tang SAM, et al. Epidemiological survey on hyperuricemia and gout among urban population of Lhasa. Med J West China. 2015a;27(10):1476–8.

    Google Scholar 

  63. Yang Y, Li L, Huang X, Yang B. Investigation on chronic diseases of cadres over 60 years old in Chengdu. Chin J Gerontol. 2015b;8(15):4341–3.

    Google Scholar 

  64. Zhou K, Xia M. Epidemiological investigation of hyperuricemia and gout in residents of Luchao port. Int J Lab Med. 2015;36(5):707–9.

    Google Scholar 

  65. Fang L, Chen Q, Wen Y, Gu J. Epidemiologic study of hyperuricemia and gout in Meizhou Area. Clin Res Papers. 2016;47(3):183–6.

    Google Scholar 

  66. Ge Y, Li T, Tao L, Pan X, Li J, Liang Y, et al. Study on the prevalence, characteristics, and clinical nursing of gout and hypertension in the Zhuang people of China. China Med Pharm. 2016;6(3):9–12.

    Google Scholar 

  67. Liu X, Wang X, Guan L, Jin H, He H, Zhang X. Prevalence and associated risk factors of hyperuricemia and gout in Han, Uygur, Kazak, Xibe of Xinjiang Ili Kazak Autonomous Prefecture. Chin J General Pract. 2016;14(7):1186–8,92.

    Google Scholar 

  68. Tan L, Zhu J, Yan M, Lin Y. Epidemiological investigation of gout and hyperuricemia in Huiyang district, Huizhou city from 2008 to 2014. Mod Diagn Treat. 2016;27(10):1919–20.

    CAS  Google Scholar 

  69. Wang S, Feng L, Song M, Su Z, Han H, Xu H, et al. Epidemiological survey of hyperuricemia and gout in newly recruited young male soldiers in Hohhot City. Med J Chinese People's Armed Police Forces [J]. 2016;27(1):5–7,11.

    Google Scholar 

  70. Zhao F. Epidemiological investigation and analysis of gout in Xiping county. For All Health. 2016;10(10):25.

    Google Scholar 

  71. Chen X, Li N, Chen Y, Mo H, Li L, Mo X. Epidemiological studies of infected factors on gout and high uric acid hematic disease in Qinzhou district. Lab Med Clinic. 2017;14(23):3470–2.

    CAS  Google Scholar 

  72. Wang T, Cai M. Investigation and analysis of disease spectrum of officers and soldiers stationed on the Qinghai-Tibet line. Med J National Defending Forces Southwest China [J]. 2017;27(4):425–6.

    Google Scholar 

  73. Zhou Y, Wang K, Sun M, Liu C. Correlation analysis between career,income and educational level and gout morbidity. J Gansu Sci [J]. 2017;29(6):57–60.

    Google Scholar 

  74. Dong P, Liu X, Du F, Chen J, Feng Y. Survey on health status and lifestyle of 3 types of occupational population in Zhushan county. Med Diet Health. 2018;12(12):131–2.

    Google Scholar 

  75. Jin S, Zhang X, Zheng H, Li F, Yao X. Epidemiological survey of hyperuricemia and gout in Bulang ethnic population in the area of Bulang mountains in Yunnan Province. J Pract Med. 2018;34(22):3796–800.

    Google Scholar 

  76. Xie L, Zhao W, Zhong Y, Wang D, Zhang X. Investigation on the prevalence of hyperuricemia among young students. Natl Med J China. 2018;98(13):987–91.

    CAS  Google Scholar 

  77. Wei R, Zhang Y, Zhang F, Peng S, Wang C, Xu G, et al. Prevalence and associated factors of hyperuricemia and gout in elderly people in Xujiahui Subdistrict,Shanghai. Chin General Pract. 2019;22(16):1954–9,72.

    Google Scholar 

  78. Liu R, Han C, Wu D, Xia X, Gu J, Guan H, et al. Prevalence of Hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int. 2015;2015:762820.

    PubMed  PubMed Central  Google Scholar 

  79. Smith E, Hoy D, Cross M, Merriman TR, Vos T, Buchbinder R, et al. The global burden of gout: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(8):1470–6.

    Article  PubMed  Google Scholar 

  80. McDougall C, Hurd K, Barnabe C. Systematic review of rheumatic disease epidemiology in the indigenous populations of Canada, the United States, Australia, and New Zealand. Semin Arthritis Rheum. 2017;46(5):675–86.

    Article  PubMed  Google Scholar 

  81. Trifiro G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, et al. Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study. Ann Rheum Dis. 2013;72(5):694–700.

    Article  CAS  PubMed  Google Scholar 

  82. Bardin T, Bouee S, Clerson P, Chales G, Flipo RM, Liote F, et al. Prevalence of gout in the adult population of France. Arthritis Care Res (Hoboken). 2016;68(2):261–6.

    Article  Google Scholar 

  83. Hakoda M. Recent trends in hyperuricemia and gout in Japan. Jpn Med Assoc J. 2012;55(4):319–23.

    Google Scholar 

  84. Kim JW, Kwak SG, Lee H, Kim SK, Choe JY, Park SH. Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015. Rheumatol Int. 2017;37(9):1499–506.

    Article  PubMed  Google Scholar 

  85. Paul BJ, James R. Gout: an Asia-Pacific update. Int J Rheum Dis. 2017;20(4):407–16.

    Article  PubMed  Google Scholar 

  86. Tu FY, Lin GT, Lee SS, Tung YC, Tu HP, Chiang HC. Prevalence of gout with comorbidity aggregations in southern Taiwan. Joint Bone Spine. 2015;82(1):45–51.

    Article  PubMed  Google Scholar 

  87. Kuo CF, Grainge MJ, See LC, Yu KH, Luo SF, Valdes AM, et al. Familial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in Taiwan. Ann Rheum Dis. 2015;74(2):369–74.

    Article  PubMed  Google Scholar 

  88. Zhang X, Meng Q, Feng J, Liao H, Shi R, Shi D, et al. The prevalence of hyperuricemia and its correlates in Ganzi Tibetan Autonomous Prefecture, Sichuan Province, China. Lipids Health Dis. 2018;17(1):235.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Jefferson JA, Escudero E, Hurtado ME, Kelly JP, Swenson ER, Wener MH, et al. Hyperuricemia, hypertension, and proteinuria associated with high-altitude polycythemia. Am J Kidney Dis. 2002;39(6):1135–42.

    Article  PubMed  Google Scholar 

  90. Wong R, Ofstedal MB, Yount K, Agree EM. Unhealthy lifestyles among older adults: exploring transitions in Mexico and the US. Eur J Ageing. 2008;5(4):311–26.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Vari R, Scazzocchio B, D'Amore A, Giovannini C, Gessani S, Masella R. Gender-related differences in lifestyle may affect health status. Ann Ist Super Sanita. 2016;52(2):158–66.

    PubMed  Google Scholar 

Download references

Funding

The authors would like to thank Xi’an Jiaotong-Liverpool University for providing support and funding for this hyperuricemia project (SURF code no. 76). The funder had no role in the design of this study and will not have any role during its execution, analyses, interpretation of the data, or decision to submit results. Jiayun Huang would like to thank her parents for providing continuous support in her studies.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization, Z.F.M.; methodology, Z.F.M. and J.H.; formal analysis, Z.F.M., J.H., Y.T., and Y.Y.L.; writing—original draft preparation, Z.F.M. and J.H.; writing—review and editing, Z.F.M., J.H., Y.T., and Y.Y.L.; funding acquisition, Z.F.M.

Corresponding authors

Correspondence to Zheng Feei Ma or Yeong Yeh Lee.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants performed by any of the authors.

Statement of Informed Consent

Informed consent was obtained from all individual participants in the studies included.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Medicine

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, J., Ma, Z.F., Tian, Y. et al. Epidemiology and Prevalence of Gout in Mainland China: an Updated Systematic Review and Meta-Analysis. SN Compr. Clin. Med. 2, 1593–1606 (2020). https://doi.org/10.1007/s42399-020-00416-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42399-020-00416-8

Keywords

Navigation